Detalles de la búsqueda
1.
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitis.
J Med Virol
; 95(2): e28452, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36597900
2.
Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan.
Hepatol Res
; 53(10): 960-967, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37332115
3.
Hepatitis C virus eradication by direct-acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low-density lipoprotein cholesterolemia without an increase in body weight.
Hepatol Res
; 53(7): 595-606, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36945790
4.
Incidence of post-transplant hepatitis B virus reactivation with the use of kidneys from donors with resolved hepatitis B virus infection.
J Viral Hepat
; 29(11): 976-985, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031873
5.
Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients.
Hepatol Res
; 52(7): 586-596, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35352445
6.
Overestimated renal function in patients with liver cirrhosis predicts poor prognosis.
Hepatol Res
; 52(7): 603-613, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35352857
7.
Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle mass.
J Viral Hepat
; 28(5): 755-763, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587828
8.
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria.
Hepatol Res
; 51(9): 979-989, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34245216
9.
Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19.
Hepatol Res
; 50(10): 1196-1200, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32729953
10.
Neutrophil gelatinase-associated lipocalin predicts the efficacy of tolvaptan for ascites in patients with liver cirrhosis.
J Gastroenterol
; 58(7): 656-667, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37103575
11.
Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C.
Viruses
; 15(1)2023 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36680221
12.
Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma.
Cancers (Basel)
; 15(3)2023 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765554
13.
Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma.
Cancers (Basel)
; 15(12)2023 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37370867
14.
Coexistence of muscle atrophy and high subcutaneous adipose tissue radiodensity predicts poor prognosis in hepatocellular carcinoma.
Front Nutr
; 10: 1272728, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37867493
15.
Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment.
Liver Cancer
; 12(2): 156-170, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37325489
16.
Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients.
PLoS One
; 17(7): e0270786, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35776720
17.
Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma.
World J Hepatol
; 14(7): 1480-1494, 2022 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36158914
18.
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication.
Sci Rep
; 12(1): 1449, 2022 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35087141
19.
Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma.
Cancers (Basel)
; 14(1)2022 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35008398
20.
Serum IL-1ß predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy.
Sci Rep
; 12(1): 16800, 2022 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36207368